Bleeding disorders pathology

Reading File
Finding Sources
Finding Sources
Searching PubMed

"bleeding disorders" pathology hemostasis

Reading File
Finding Sources
Finding Sources
Reading File
Finding Sources
Finding Sources
Reading File
Finding Sources
Reading File
Loading Image
Searching Images

hemophilia bleeding disorder coagulation factor deficiency pathology

I now have all the content needed for a comprehensive answer. Let me compile it.

Bleeding Disorders — Pathology

Source: Robbins & Kumar Basic Pathology, 10th ed.

Overview & Classification

Bleeding disorders are characterized by abnormal bleeding that may be spontaneous or provoked by trauma/surgery. They arise from defects in one or more components of hemostasis:
CategoryExamples
Vascular fragilityScurvy, amyloidosis, glucocorticoid excess, vasculitis
Platelet disordersThrombocytopenia, qualitative platelet defects
Coagulation factor deficienciesHemophilia A & B, von Willebrand disease
Mixed / consumptiveDIC

Diagnostic Laboratory Tests

TestPathway AssessedProlonged By
PT (Prothrombin Time)Extrinsic + common pathwaysDeficiency of factors V, VII, X, prothrombin, or fibrinogen; acquired inhibitors
PTT (Partial Thromboplastin Time)Intrinsic + common pathwaysDeficiency of factors V, VIII, IX, X, XI, XII, prothrombin, or fibrinogen
Platelet countQuantitative platelet assessmentReference: 150,000–450,000/μL
Platelet function testsAggregation studies, vWF assaysQualitative defects, vWF deficiency
Specific factor assaysIndividual factor levelsFactor-specific deficiencies

1. Vascular Fragility Disorders

Bleeding due purely to vascular wall weakness presents with:
  • "Spontaneous" petechiae and ecchymoses in skin and mucous membranes (likely from trivial trauma)
  • Normal coagulation tests (PT, PTT, platelet count)
Causes include:
  • Scurvy — vitamin C deficiency impairs collagen synthesis
  • Amyloidosis — amyloid deposits in vessel walls
  • Chronic glucocorticoid use — atrophies perivascular connective tissue
  • Hereditary connective tissue disorders (e.g., Ehlers-Danlos)
  • Infectious/hypersensitivity vasculitides

2. Thrombocytopenia

Defined as platelet count <150,000/μL. Clinically significant spontaneous bleeding rarely occurs until counts fall below ~20,000/μL. Causes include:
  • Decreased production: bone marrow failure, aplastic anemia, infiltrative neoplasms
  • Increased destruction:
    • Immune thrombocytopenic purpura (ITP) — autoantibodies (usually IgG) against platelet membrane glycoproteins (GPIIb/IIIa); splenic destruction
    • Drug-induced (heparin-induced thrombocytopenia, HIT)
    • TTP/HUS — microangiopathic consumption
  • Sequestration: hypersplenism
  • Dilutional: massive transfusion
Qualitative platelet defects (normal count but abnormal function):
  • Uremia (acquired)
  • Glanzmann thrombasthenia — absent GPIIb/IIIa (inherited)
  • Bernard-Soulier syndrome — absent GPIb (collagen receptor)
  • Aspirin/NSAIDs — irreversible COX inhibition

3. Coagulation Factor Deficiencies

Von Willebrand Disease (vWD)

The most common inherited bleeding disorder. vWF has two critical roles:
  1. Mediates platelet adhesion to subendothelial collagen
  2. Carries factor VIII in plasma (protects it from proteolysis)
TypeDefectFrequency
Type 1Quantitative reduction (partial)~75% of cases
Type 2Qualitative dysfunctionVariable subtypes
Type 3Complete absence (severe)Rare; AR
Lab findings: Prolonged bleeding time, prolonged PTT (due to low factor VIII), normal PT. Ristocetin cofactor assay is reduced.

Hemophilia A: Factor VIII Deficiency

  • X-linked recessive (males affected; females carriers)
  • Accounts for ~80% of hemophilias
  • Factor VIII is a cofactor for factor IXa in the intrinsic pathway
Clinical features (severity depends on factor VIII level):
  • Severe (<1% factor VIII): spontaneous hemarthroses, deep muscle hematomas
  • Moderate (1–5%): bleeding after mild trauma
  • Mild (5–30%): bleeding only after significant trauma/surgery
Hallmarks:
  • Hemarthrosis (bleeding into joints) → most common; leads to chronic joint deformity
  • Deep tissue hematomas
  • Post-circumcision / post-procedure bleeding
  • Petechiae and superficial bruising are not features (contrast with platelet disorders)
Lab: Prolonged PTT, normal PT, normal platelet count. Specific factor VIII assay confirms diagnosis.
Treatment: Recombinant factor VIII infusion. A bispecific antibody (emicizumab) that bridges factor IX and factor X bypasses the need for factor VIII entirely — particularly useful in patients who develop anti-factor VIII inhibitor antibodies (~15% of severe HA).
Clinical bleeding manifestations in hemophilia — ecchymosis, hemarthrosis, and hematoma

Hemophilia B: Factor IX Deficiency

  • X-linked recessive, clinically indistinguishable from hemophilia A
  • Much less common (~20% of hemophilias)
  • Lab: Prolonged PTT, normal PT
  • Treatment: Recombinant factor IX infusion

4. Disseminated Intravascular Coagulation (DIC)

Probably causes more bleeding than all congenital coagulation disorders combined, as it complicates many acute illnesses.

Pathogenesis

DIC is triggered by two main mechanisms:
  1. Release of tissue factor/procoagulants into circulation:
    • Obstetric emergencies (amniotic fluid, placental tissue)
    • Cancer cells (esp. acute promyelocytic leukemia, adenocarcinomas)
    • Bacterial endotoxins → monocyte IL-1/TNF → upregulate tissue factor on endothelium + downregulate thrombomodulin (→ less protein C activation)
  2. Widespread endothelial injury:
    • Antigen-antibody complex deposition (SLE)
    • Temperature extremes (heat stroke, burns)
    • Infections (meningococcemia, rickettsiae)
    • Sepsis
Pathophysiology of DIC — tissue factor release, microvascular thrombosis, consumptive coagulopathy, and secondary fibrinolysis

Major DIC Triggers (Table 10.10)

CategoryExamples
ObstetricAbruptio placentae, retained nonviable fetus, amniotic fluid embolism, eclampsia
InfectionsGram-negative/positive sepsis, meningococcemia, Rocky Mountain spotted fever, malaria
NeoplasmsPancreatic/prostatic/lung carcinoma, acute promyelocytic leukemia
Massive tissue injuryTrauma, burns, extensive surgery (especially brain trauma)
MiscellaneousIntravascular hemolysis, snakebite, giant hemangioma, shock, liver disease

Consequences of DIC (Dual Paradox)

1. Thrombotic phase → widespread microvascular fibrin thrombi:
  • Ischemia and microinfarcts (kidneys, adrenals, brain, heart)
  • Microangiopathic hemolytic anemia — RBCs sheared by fibrin strands
2. Hemorrhagic phase (consumptive coagulopathy):
  • Platelets and clotting factors consumed faster than they are replenished
  • Secondary fibrinolysis activated → plasmin cleaves fibrin AND factors V and VIII
  • Fibrin degradation products (FDPs) inhibit platelet aggregation, have anti-thrombin activity, and impair fibrin polymerization → compounding hemorrhage

Morphology in DIC

Microthrombi are found in arterioles and capillaries of:
  • Kidneys — glomerular fibrin thrombi → focal glomerulitis → cortical microinfarcts → bilateral renal cortical necrosis (severe)
  • Adrenals → Waterhouse-Friderichsen syndrome
  • Brain → microinfarcts + foci of hemorrhage
  • Lungs, heart, liver also affected

Lab Findings in DIC

TestFinding
PT & PTTBoth prolonged
Platelet countLow (consumptive)
FibrinogenDecreased
D-dimer / FDPsElevated (fibrinolysis)
Peripheral smearSchistocytes (microangiopathic hemolysis)

Summary: Distinguishing Patterns

FeatureVascularPlatelet DefectCoagulation Factor DefectDIC
Petechiae+++±
Hemarthrosis++
PTNN↑ (factor VII, X, V, II)
PTTNN↑ (VIII, IX, XI, XII)
Platelet countN↓ or NN
Bleeding timeN

Robbins & Kumar Basic Pathology, 10th ed., pp. 426–431
This is a shared conversation. Sign in to Orris to start your own chat.